CLINICAL TRIAL AGREEMENTClinical Trial Agreement • August 19th, 2024
Contract Type FiledAugust 19th, 2024WHEREAS, Sponsor, a research-driven pharmaceutical company, is conducting a clinical trial of BI 765845 (“Investigational Product”) according to the Clinical Trial Protocol for BI Trial No. 1478-0002 including all documents attached thereto and referenced therein (“Protocol”) entitled
CLINICAL TRIAL AGREEMENT(“Agreement”) between Boehringer Ingelheim RCV GmbH & Co KGDr. Boehringer-Gasse 5-11, 1121 Vienna, AustriaVAT-ID-No.: ATU 64226215represented by DOKUMEDS SIA Katrinas dambis 20, Riga, LV-1045 Latvia,based on the Letter of...Clinical Trial Agreement • July 15th, 2021
Contract Type FiledJuly 15th, 2021RECITALS WHEREAS, Sponsor, a research-driven pharmaceutical company, is sponsoring and conducting a clinical trial of VYMAZÁNO (“Investigational Product”) according to the Clinical Trial Protocol for BI Trial No. VYMAZÁNOincluding all documents attached thereto and referenced therein (“Protocol”) entitled VYMAZÁNO as amended (“Trial”), incorporated herein by reference and provided to Institution and/or Investigator by the Sponsor under separate cover in the regulatory document package; and WHEREAS, Sponsor has authorized DOKUMEDS SIA, to carry out on behalf of Sponsor certain of Sponsor’s responsibilities with respect to the Trial, which may include, but are not limited to, Agreement negotiation and management; and WHEREAS, Sponsor seeks to engage the services of Institution and Investigator to carry out the Trial in accordance with the Protocol; and WHEREAS, Institution operates a facility engaged in research activities and services including the creation, implementation and documenta